Approval · Notice of Compliance 15706 · 2014
GLICLAZIDE: Notice of Compliance 15706
Issued June 9, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15706
- Date
- June 9, 2014
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Therapeutic class
- Oral hypoglycemic agent
- Canadian reference product
- DIAMICRON (Servier Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLICLAZIDE | 02287072 | Marketed |
Medicinal ingredients
- GLICLAZIDE 80 MG per TAB